A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
- DOI
- 10.1080/19490976.2024.2338322
- Published
- 2024 Jan-Dec
- Container
- Gut microbes
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/19490976.2024.2338322,
title = {A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.},
author = {Srivastava S and Basak U and Naghibi M and Vijayakumar V and Parihar R and Patel J and Jadon PS and Pandit A and Dargad RR and Khanna S and Kumar S and Day R},
year = {2024},
journal = {Gut microbes},
doi = {10.1080/19490976.2024.2338322},
url = {https://doi.org/10.1080/19490976.2024.2338322}
}RIS
TY - JOUR TI - A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome. AU - Srivastava S AU - Basak U AU - Naghibi M AU - Vijayakumar V AU - Parihar R AU - Patel J AU - Jadon PS AU - Pandit A AU - Dargad RR AU - Khanna S AU - Kumar S AU - Day R PY - 2024 JO - Gut microbes DO - 10.1080/19490976.2024.2338322 UR - https://doi.org/10.1080/19490976.2024.2338322 ER -
APA
S, S., U, B., M, N., V, V., R, P., J, P., PS, J., A, P., RR, D., S, K., S, K., & R, D. (2024). A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.. Gut microbes. https://doi.org/10.1080/19490976.2024.2338322
Source records
- pubmed · retrieved 2026-09-27T10:50:55.508Z